Immediate Impact
68 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Works of Laura Boullerot being referenced
The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors
2022
Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Laura Boullerot | 159 | 141 | 78 | 16 | 254 | |
| Jichang Han | 173 | 158 | 57 | 11 | 284 | |
| Hirotoshi Kawashima | 151 | 73 | 53 | 15 | 291 | |
| Mizuha Kosugi‐Kanaya | 199 | 85 | 75 | 14 | 317 | |
| Qinyuan Liao | 165 | 70 | 159 | 19 | 312 | |
| Ichwaku Rastogi | 139 | 112 | 122 | 13 | 306 | |
| Ana Henriques | 139 | 92 | 79 | 14 | 237 | |
| Felix S.R. Picard | 139 | 77 | 57 | 14 | 238 | |
| Maya Hassane | 180 | 66 | 58 | 12 | 263 | |
| Chenglu Qin | 153 | 107 | 53 | 17 | 275 | |
| Rupert Engelhardt | 97 | 64 | 79 | 16 | 310 |
All Works
Login with ORCID to disown or claim papers
Loading papers...